Louisiana State Employees Retirement System Invests $1.14 Million in Cabot Corporation $CBT

Louisiana State Employees Retirement System purchased a new stake in shares of Cabot Corporation (NYSE:CBT) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 15,100 shares of the specialty chemicals company’s stock, valued at approximately $1,137,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CBT. NewEdge Advisors LLC grew its stake in Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after buying an additional 947 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after acquiring an additional 108,645 shares during the last quarter. Empowered Funds LLC boosted its holdings in shares of Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after acquiring an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after acquiring an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its position in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Stock Performance

CBT stock opened at $86.29 on Friday. The company has a 50 day moving average price of $84.52 and a 200 day moving average price of $76.46. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The stock has a market capitalization of $4.45 billion, a PE ratio of 16.31, a price-to-earnings-growth ratio of 11.36 and a beta of 0.83.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Analysts forecast that Cabot Corporation will post 6.34 EPS for the current year.

Cabot Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were issued a $0.4725 dividend. This is a positive change from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 annualized dividend and a yield of 2.2%. The ex-dividend date was Friday, May 29th. Cabot’s dividend payout ratio (DPR) is 35.73%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CBT. Truist Financial assumed coverage on Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. JPMorgan Chase & Co. raised their target price on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. UBS Group lifted their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $85.80.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.